Case Studies | Medicine Science | Morocco | Volume 7 Issue 6, June 2018
Direct-Acting Antiviral Hepatitis C Therapy in Patients with Chronic Renal Failure
Abstract: The prevalence of hepatitis C virus (HCV) infection is estimated at 3 % in the global population, it is higher in patients on hemodialysis, the treatment of viral hepatitis C has increased with appearance of new antiviral molecules specifically targeting the virus that has revolutionized the therapeutic response Materials and methods this is a retrospective study from 2015 to February 2018 in the service of hepato-gastroenterology, University Hospital Mohamed VI, Marrakech including 33 hemodialysis patients or follow-up for renal insufficiency not dialyzed and put on treatment by sofosbuvir400mg / day in association with daclatasvir 60mg / d including 2 patients with severe renal insufficiency (creatinine clearance
Keywords: viral hepatitis C, hemodialysis, renal failure, direct antivirals, response, adverse effects
Edition: Volume 7 Issue 6, June 2018,
Pages: 1022 - 1025
How to Cite this Article?
K. Krati, A. Benayad, Z. Semalni, S. Oubaha, "Direct-Acting Antiviral Hepatitis C Therapy in Patients with Chronic Renal Failure", International Journal of Science and Research (IJSR), Volume 7 Issue 6, June 2018, pp. 1022-1025, https://www.ijsr.net/get_abstract.php?paper_id=ART20182944
How to Share this Article?
Similar Articles with Keyword 'hemodialysis'
Recurrent Atypical Hemolytic Uremic Syndrome Post-Renal Transplantation: Case Report Treated with Eculizumab
Abdullah Kashgary MD FRCPC
Epidemiological Profile of Patients of End Stage Renal Disease (ESRD) for Hemodialysis (HD) at Tertiary Care Rural Hospital of Subhimayalian Region of India